4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-20-011261
President & CEO sold 8,448 shares at $22.35 ($188,813)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2020-02-18 | Sale | −8,448 | $22.35 | $188,813 | 384,871 | D: show line 1 in the form |
| Open-market sales · 8,448 sh · avg $22.35 · $188,813 | |||||||
Loading xslF345X03/doc4.xml…